These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 33648862)
1. Do-It-Yourself Artificial Pancreas System Use in Pregnant Women With Type 1 Diabetes in a Real-World Setting: 2 Case Reports. Lemieux P; Yamamoto JM; Donovan LE Can J Diabetes; 2021 Dec; 45(8):804-808.e2. PubMed ID: 33648862 [No Abstract] [Full Text] [Related]
2. Changes in Ambulatory Glucose Profile in Patients With Type 1 Diabetes Mellitus After Switching From Sensor-Augmented Insulin Pump Therapy to a Do-It-Yourself Artificial Pancreas System: A Retrospective Data Analysis of Real-World Data. Müller-Korbsch M; Frühwald L; Kietaibl A J Diabetes Sci Technol; 2022 Nov; 16(6):1577-1579. PubMed ID: 35915931 [No Abstract] [Full Text] [Related]
3. Comparing the technical reliability and insulin dosing of a "do-it-yourself artificial pancreas" with a commercial hybrid closed-loop system in a "shadow-mode" scenario: An exploratory study. Künzler J; Züger T; Stettler C; Laimer MW; Melmer A Diabetes Obes Metab; 2023 Sep; 25(9):2780-2783. PubMed ID: 37311723 [No Abstract] [Full Text] [Related]
4. Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System. Dodesini AR; Borella ND; Lepore G; Bonfadini S; Corsi A; Scaranna C; Bellante R; Trevisan R Diabetes Technol Ther; 2023 Jul; 25(7):516-518. PubMed ID: 36930146 [No Abstract] [Full Text] [Related]
5. Real world evidence of the efficacy of two hybrid closed loop systems for children and adults with type 1 diabetes with some clinical warnings. Henry Z; Villar Fimbel S; Bendelac N; Thivolet C Diabetes Metab; 2022 Nov; 48(6):101396. PubMed ID: 36252880 [No Abstract] [Full Text] [Related]
6. Development and Future of Automated Insulin Delivery (AID) Systems. Garg SK; McVean JJ Diabetes Technol Ther; 2024 Mar; 26(S3):1-6. PubMed ID: 38377322 [No Abstract] [Full Text] [Related]
7. Two Subsequent Pregnancies in a Woman With Type 1 Diabetes: Artificial Pancreas Was a Gamechanger. Schütz-Fuhrmann I; Schütz AK; Eichner M; Mader JK J Diabetes Sci Technol; 2020 Sep; 14(5):972-973. PubMed ID: 32059616 [No Abstract] [Full Text] [Related]
9. Use of Advanced Hybrid Closed-Loop System in a Patient with Pancreas Cancer. Hacisahinogullari H; Caklili OT; Saribeyliler G; Rasulova N; Selcukbiricik O; Gul N; Uzum AK; Karsidag K Diabetes Technol Ther; 2022 Sep; 24(9):675-676. PubMed ID: 35349364 [No Abstract] [Full Text] [Related]
10. Large Treatment Effects With Automated Insulin Delivery System. Slomski A JAMA; 2022 Oct; 328(16):1581-1582. PubMed ID: 36282258 [No Abstract] [Full Text] [Related]
11. Who needs an artificial pancreas? (?). Winikoff J; Drexler A J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378 [TBL] [Abstract][Full Text] [Related]
12. Sensor augmented pump therapy with predictive suspension function for low glucose levels reduces time in hypoglycaemia in pregnant women with type 1 diabetes. Roberto DA; Elena C; Anna C; Cristiana S; Rosalia B; Mascia A; Silvia B; Diego BN; Giuseppe L; Roberto T Acta Diabetol; 2023 Sep; 60(9):1283-1285. PubMed ID: 37191717 [No Abstract] [Full Text] [Related]
13. Use of the Interoperable Artificial Pancreas System for Type 1 Diabetes Management During Psychological Stress. Pinsker JE; Deshpande S; McCrady-Spitzer S; Church MM; Kaur RJ; Perez J; Desjardins D; Piper M; Reid C; Doyle FJ; Kudva YC; Dassau E J Diabetes Sci Technol; 2021 Jan; 15(1):184-185. PubMed ID: 32783473 [No Abstract] [Full Text] [Related]
14. Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting. Castellanos LE; Balliro CA; Sherwood JS; Jafri R; Hillard MA; Greaux E; Selagamsetty R; Zheng H; El-Khatib FH; Damiano ER; Russell SJ Diabetes Care; 2021 Jun; 44(6):e118-e120. PubMed ID: 33906916 [No Abstract] [Full Text] [Related]
15. Type 1 diabetes: NICE recommends new "artificial pancreas" technology. Iacobucci G BMJ; 2023 Jan; 380():55. PubMed ID: 36627118 [No Abstract] [Full Text] [Related]
17. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes. Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176 [TBL] [Abstract][Full Text] [Related]
18. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals. Jennings P; Hussain S J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570 [TBL] [Abstract][Full Text] [Related]
19. A review on artificial pancreas and regenerative medicine used in the management of Type 1 diabetes mellitus. Sachdeva P; M AR; Shukla R; Sahani A J Med Eng Technol; 2022 Nov; 46(8):693-702. PubMed ID: 35801984 [TBL] [Abstract][Full Text] [Related]
20. Where Do We Stand with Closed-Loop Systems and Their Challenges? Jackson M; Castle JR Diabetes Technol Ther; 2020 Jul; 22(7):485-491. PubMed ID: 32069100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]